ClinicalTrials.govpublic full text
Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors
cancer (advanced stage), esophogeal, gastric, lung, cholangiocarcinoma, melanoma, hepatocellular carcinoma, immune checkpoint inhibitor, microsatellite instability-high, renal cell carcinoma, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 881858
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.